Summary
Pancreatic spasmolytic polypeptide (PSP) is a peptide that is isolated from the porcine pancreas and that affects intestinal motility and growth of intestinal tumour cells in vitro. The peptide was recently demonstrated to be present in large amounts in pancreatic juice. The cellular origin of the peptide, however, is largely unclarified and the localization was therefore studied of PSP in pigs using immunohistochemistry. Positive immunoreactions were seen in the pancreas, the stomach, the duodenum, the jejunum and the ileum. In the pancreas, the PSP immunoreaction was seen in all acinar cells; no immunoreaction was seen in the endocrine islets. In the stomach, it was localized to the mucous cells of the glands in the cardiac gland region, the corpus and the pylorus. In the duodenum a strong immunoreaction was present in Brunner's glands and in the cells of their excretory ducts. In the jejunum and ileum, PSP immunoreactivity was seen in some of the cells in the epithelium of the crypts of Lieberkühn. A peptide chromatographically identical to highly purified PSP was identified in pancreas and stomach extracts. Thus epithelial cells in all parts of the stomach and small intestine contribute to the supply of PSP to the gut lumen.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Frandsen EK (1988) Receptor binding of pancreatic spasmolytic polypeptide in intestinal mucosal cells and membranes. Regul Pept 20:45–52
Harlow E, Lane D (1988) Antibodies. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 471–510
Hoosein NM, Thim L, Jørgensen KH, Brattain MG (1989) Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett 247:303–306
Jørgensen KD, Diamant B, Jørgensen KH, Thim L (1982a) Pancreatic spamsolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spamolytic and gastric acid secretion inhibitory effects. Regul Pept 3:231–243
Jørgensen KH, Thim L, Jacobsen HE (1982b) Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 3:207–219
Newgard CB, Holst JJ (1981) Heterogeneity of somatostatin-like immunoreactivity in extracts of porcine, canine and human pancreas. Acta Endocrinol (Copenh) 98:564–572
Rasmussen TN, Thim L, Raaberg L, Harling H, Holst JJ (1990) Pancreatic spasmolytic polypeptide (PSP), a potential growth factor for the intestine: localization and control of secretion. Digestion 46 (Suppl 1):90
Sternberger L (1974) Immunohistochemistry. Prentice Hall, Englewood Cliffs, New York, pp 129–171
Thim L (1989) A new family of growth factor-like peptides. “Trefoil” disulphide loop structure as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 250:85–90
Thim L, Jørgensen KH, Jørgensen KD (1982) Pancreatic spasmolytic polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul Pept 3:221–230
Tomasetto C, Rio MC, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R (1990) hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 2:407–414
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rasmussen, T.N., Raaberg, L., Poulsen, S.S. et al. Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig. Histochemistry 98, 113–119 (1992). https://doi.org/10.1007/BF00717002
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00717002